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A B S T R A C T  
The development of the COVID-19 vaccine is currently quite encouraging amid increasing mortality and transmission of the COVID-19 virus 
in various countries. Apart from vaccination, the government also needs to consider vitamin D supplementation policies because it has a 
significant role in boosting the immune system. 
The world health organization (who) currently records as 
many as 79,673,754 patients confirmed positive for 
COVID-19 and the number of deaths reaching 1,761,381 
people worldwide1. Several vaccines have been devel-
oped to prevent the transmission of COVID-19 by several 
pharmaceutical companies in various countries. It is rec-
orded that more than 60 vaccine candidates have been 
being formulated, and some even have had their distribu-
tion permit from the food and drug administration of sev-
eral countries2. However, implementation of the commu-
nity has not been carried out yet due to several issues, 
including their effectiveness and safety of the vaccine it-
self.  
 
Amid the increasing mortality and transmission of the 
COVID-19 virus and the fact that the vaccine is not ready, 
maintaining a robust immune system is the key to protect-
ing our bodies. Vitamin D has a vital role in the case. Cal-
citriol (active vitamin D)-- 1,25-dihydroxycholecalciferol 
(1,25(OH)2D)-- is the active form of vitamin D from 7-de-
hydrocholesterol from the consumption of milk, cereal, 
cheese, and fish oil plus ultraviolet B radiation (UVB) on 
the skin with the help of liver and kidney enzymes3. 
 
Previous studies have shown that vitamin D can reduce 
the risk of respiratory tract infections and increase 
adaptive cellular immunity4–8. Other studies with clinical 
outcomes of COVID-19 patients based on vitamin D status 
have proved their crucial role in the prevention measure 
and the treatment of COVID-19 patients. Its deficiency is 
significantly associated with an increased risk of COVID-
199. Patients with severe COVID-19 had more vitamin D 
deficiency than those with mild cases (OR = 1.64; 95% CI 
= 1.30-2.09) and increased hospitalization (OR = 1.81, 
95% CI = 1.41- 2.21) and death (OR = 1.82, 95% CI = 
1.06-2.58)10. 
 
Although no clinical trials have been conducted to deter-
mine the specific effects of vitamin D in suppressing 
COVID-19, a research with a quasi-experimental design 
regarding the provision of bolus vitamin D3 supplementa-
tion in the elderly with COVID-19 obtained results that giv-
ing vitamin D3 supplementation by bolus during or just be-
fore COVID-19 has an impact on the severity and better 
survival rates11.  
 
The policy of vitamin supplementation has been imple-
mented in Indonesia, namely the Minister of Health Regu-
lation number 21 of 2015 on the provision of vitamin A 
100,000 IU supplementation for infants aged six to eleven 
months, vitamin a 200,000 IU for children of twelve to fifty-
nine months, and high doses of post-partum mothers to 
reduce the risk of morbidity and mortality for mothers and 
children under five. However, for vitamin D supplementa-
tion policies, long-term prospective intervention studies 
are needed to ensure that it can help prevent and treat 
COVID-19. 
 
Although specific clinical trials have not been undertaken, 
research reviews show that the vitamin is useful in increas-
ing immunity. The recommendations of the studies can 
serve as a basis for consideration for vitamin D supple-
mentation. They argue that an optimal vitamin D level in 
the body should be maintained in the range of 100–150 
nmol/l (40–60 ng/ml). Taking vitamin D at doses of 1000–
4000 IU/day can maintain vitamin D levels ≥30 ng/ml and 
is beneficial for patients with chronic disease. The sun ex-
posure to the arms and legs (18% of body surface) at 
11.00-14.00, until the skin turns slightly reddish, is equiva-
lent to about 3600 IU of cholecalciferol supplementation. If 
this is regularly practiced three times a week, it will provide 
a good vitamin D12. 
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